Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine plus carboplatin versus carboplatin alone in progressive advanced ovarian cancer
2006-002324-41Phase 2Terminated
- Sponsor
- Cancer Research UK
- Start
- Oct 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC) comparing Decitabine + carboplatin with Carboplatin alone (2 arms). Primary endpoints: Primary response rate, Response rate in hMLH1-methylated subgroup and 1 more. Started Oct 2006; status: terminated.
02
Drugs
decitabinecarboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on 2006-002324-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002324-41.